Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution†
Abstract
The
* Corresponding authors
a
Department of Chemistry, The University of Auckland, Private Bag 92019, Auckland, New Zealand
E-mail:
r.anderson@auckland.ac.nz
Fax: +64 9 3737422
Tel: +64 9 3737599 extn 88315
b Auckland Cancer Society Research Centre, The University of Auckland, Private Bag 92019, Auckland, New Zealand
The
R. F. Anderson, S. S. Shinde, A. Maroz, M. Boyd, B. D. Palmer and W. A. Denny, Org. Biomol. Chem., 2008, 6, 1973 DOI: 10.1039/B801859F
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content